ArticleJAMA network open2022

Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine.

Koichi Furukawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.